已收盤 02-28 16:00:00 美东时间
0.000
0.00%
Shares of Zevra (NASDAQ:ZVRA) climbed 16% Wednesday ahead of an FDA advisory committee meeting on Friday that will discuss the company’s resubmitted market application for arimoclomol. The Danish comp...
2024-08-01 02:49
Equities research analysts at StockNews.com began coverage on shares of Zevra T...
2023-04-02 13:23
Equities research analysts at StockNews.com began coverage on shares of Zevra T...
2023-04-02 13:22
StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get...
2023-03-19 02:53
北京时间2023年03月15日23时17分,Zevra Therapeutics Inc(ZVRA.us)股票出现波动,股价大幅下跌5.01%。截至发稿,该股报...
2023-03-16 00:37
Equities research analysts at StockNews.com assumed coverage on shares of Zevra...
2023-03-10 13:21
Zevra Therapeutics, Inc. (NASDAQ:KMPH – Get Rating) was the recipient of a larg...
2023-03-08 19:54
Zevra Therapeutics(ZVRA.US):2022年Q4财报实现营收230万美元,前值为260万美元,预期值为320万美元,比市场预期低28.1...
2023-03-07 21:37
Zevra Therapeutics (NASDAQ:KMPH – Get Rating) is scheduled to issue its quarter...
2023-03-05 14:53
北京时间2023年02月18日03时22分,Kempharm Inc(KMPH.us)股票出现异动,股价快速拉升5.05%。截至发稿,该股报5.59美元/股,成...
2023-02-18 04:30